<?xml version="1.0" encoding="UTF-8"?>
<p>Therefore the aim of this review is to summarise the evidence and discuss in detail the data regarding the risks of developing COVID‐19, strategies that can be implemented to reduce these risks and issues surrounding the treatment of COVID‐19, including potential drug interactions and IBD medication management, in the IBD patient cohort.</p>
